Gates Foundation supports development of Immunocore ’s therapeutics for infectious diseases

Immunocore has secured up to $40m in investment from Bill& Melinda Gates Foundation to boost the development of soluble T-cell receptor (TCR)-based therapeutics to treat infectious diseases, in particular tuberculosis (TB) and human immunodeficiency …
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news